0.035149
0.000000
0.000000
0.000000
0.035149
0.000000
0.000000
0.000000
0.015188
0.00000
0.00000
0.00000
Loll, P.J.
Bevivino, A.E.
Korty, B.D.
Axelsen, P.H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
28.450
28.450
65.840
C8 H9 N O4
183.161
(2S)-amino(3,5-dihydroxyphenyl)ethanoic acid
L-peptide linking
C2 H4 O2
60.052
ACETIC ACID
non-polymer
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C6 H12 O6
180.156
beta-D-glucopyranose
beta-D-glucose; D-glucose; glucose
D-saccharide, beta linking
Cl -1
35.453
CHLORIDE ION
non-polymer
C8 H9 N O3
167.162
(2R)-amino(4-hydroxyphenyl)ethanoic acid
D-peptide linking
H2 O
18.015
WATER
non-polymer
C7 H15 N O2
145.199
N-methyl-D-leucine
D-peptide linking
C9 H10 Cl N O4
231.633
n
(betaR)-3-chloro-beta-hydroxy-L-tyrosine
L-peptide linking
C9 H10 Cl N O4
231.633
(betaR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE
D-peptide linking
C7 H15 N O3
161.199
vancosamine
(1R,3S,4S,5S)-3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranose
L-saccharide, alpha linking
N
1
N
N
N
2
N
O
Y
3
N
C
Y
4
N
C
Y
5
N
C
Y
6
N
C
N
7
N
O
Y
8
N
C
Y
9
N
C
N
10
S
C
N
11
N
C
N
12
N
O
N
13
N
O
N
14
N
H
N
15
N
H
N
16
N
H
N
17
N
H
N
18
N
H
N
19
N
H
N
20
N
H
N
21
N
H
N
22
N
H
N
23
N
C
N
24
N
O
N
25
N
O
N
26
N
C
N
27
N
H
N
28
N
H
N
29
N
H
N
30
N
H
N
31
N
N
N
32
S
C
N
33
N
C
N
34
N
O
N
35
N
C
N
36
N
C
N
37
N
O
N
38
N
N
N
39
N
O
N
40
N
H
N
41
N
H
N
42
N
H
N
43
N
H
N
44
N
H
N
45
N
H
N
46
N
H
N
47
N
H
N
48
R
C
N
49
S
C
N
50
S
C
N
51
R
C
N
52
N
C
N
53
R
C
N
54
N
O
N
55
N
O
N
56
N
O
N
57
N
O
N
58
N
O
N
59
N
O
N
60
N
H
N
61
N
H
N
62
N
H
N
63
N
H
N
64
N
H
N
65
N
H
N
66
N
H
N
67
N
H
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
CL
N
73
N
N
N
74
R
C
N
75
N
C
N
76
N
O
N
77
N
O
Y
78
N
C
Y
79
N
C
Y
80
N
C
Y
81
N
C
N
82
N
O
Y
83
N
C
Y
84
N
C
N
85
N
H
N
86
N
H
N
87
N
H
N
88
N
H
N
89
N
H
N
90
N
H
N
91
N
H
N
92
N
H
N
93
N
H
N
94
N
O
N
95
N
H
N
96
N
H
N
97
N
N
N
98
N
C
N
99
R
C
N
100
N
C
N
101
N
O
N
102
N
C
N
103
N
C
N
104
N
C
N
105
N
C
N
106
N
O
N
107
N
H
N
108
N
H
N
109
N
H
N
110
N
H
N
111
N
H
N
112
N
H
N
113
N
H
N
114
N
H
N
115
N
H
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
H
N
120
N
H
N
121
N
H
N
122
N
N
N
123
S
C
N
124
N
O
Y
125
N
C
Y
126
N
C
Y
127
N
C
Y
128
N
C
Y
129
N
C
Y
130
N
C
N
131
R
C
N
132
N
CL
N
133
N
O
N
134
N
C
N
135
N
O
N
136
N
O
N
137
N
H
N
138
N
H
N
139
N
H
N
140
N
H
N
141
N
H
N
142
N
H
N
143
N
H
N
144
N
H
N
145
N
H
N
146
N
H
N
147
N
N
N
148
R
C
N
149
N
C
N
150
N
O
N
151
N
O
N
152
R
C
N
153
N
O
Y
154
N
C
Y
155
N
C
Y
156
N
C
Y
157
N
C
N
158
N
CL
Y
159
N
C
Y
160
N
C
N
161
N
O
N
162
N
H
N
163
N
H
N
164
N
H
N
165
N
H
N
166
N
H
N
167
N
H
N
168
N
H
N
169
N
H
N
170
N
H
N
171
N
H
N
172
R
C
N
173
N
C
N
174
S
C
N
175
N
N
N
176
N
C
N
177
S
C
N
178
N
O
N
179
S
C
N
180
N
O
N
181
N
C
N
182
N
O
N
183
N
H
N
184
N
H
N
185
N
H
N
186
N
H
N
187
N
H
N
188
N
H
N
189
N
H
N
190
N
H
N
191
N
H
N
192
N
H
N
193
N
H
N
194
N
H
N
195
N
H
N
196
N
H
N
197
N
H
N
1
N
sing
N
2
N
sing
Y
3
N
sing
Y
4
N
doub
Y
5
N
doub
Y
6
N
sing
N
7
N
sing
Y
8
N
doub
Y
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
doub
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
doub
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
sing
N
34
N
sing
N
35
N
sing
N
36
N
doub
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
doub
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
sing
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
sing
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
sing
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
sing
N
75
N
sing
N
76
N
doub
N
77
N
sing
N
78
N
sing
Y
79
N
doub
Y
80
N
sing
Y
81
N
sing
N
82
N
sing
Y
83
N
doub
N
84
N
sing
N
85
N
sing
Y
86
N
sing
N
87
N
sing
Y
88
N
doub
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
doub
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
sing
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
sing
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
sing
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
sing
N
118
N
sing
Y
119
N
sing
Y
120
N
doub
Y
121
N
doub
Y
122
N
sing
Y
123
N
doub
N
124
N
sing
Y
125
N
sing
N
126
N
sing
N
127
N
doub
N
128
N
sing
N
129
N
sing
N
130
N
sing
N
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
sing
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
sing
N
144
N
sing
N
145
N
doub
N
146
N
sing
N
147
N
sing
N
148
N
sing
N
149
N
sing
Y
150
N
doub
Y
151
N
sing
Y
152
N
sing
Y
153
N
doub
Y
154
N
doub
Y
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
sing
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
sing
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
N
190
N
sing
N
191
N
sing
N
192
N
sing
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
119
1516
10.1021/JA963566P
Simultaneous Recognition of a Carboxylate-Containing Ligand and an Intramolecular Surrogate Ligand in the Crystal Structure of an Asymmetric Vancomycin Dimer.
1997
10.2210/pdb1aa5/pdb
pdb_00001aa5
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
98
1
CCD
1996-04
ADSC
M
x-ray
1
0.85
1.0
X8C
NSLS
0.85
SYNCHROTRON
NSLS BEAMLINE X8C
1149.977
VANCOMYCIN
2
syn
polymer
323.340
vancosamine-(1-2)-beta-D-glucopyranose
2
man
branched
60.052
ACETIC ACID
1
syn
non-polymer
35.453
CHLORIDE ION
4
syn
non-polymer
18.015
water
55
nat
water
no
yes
(MLU)(OMZ)N(GHP)(GHP)(OMY)(3FG)
XXNGGYX
A,B
polypeptide(L)
n
n
n
n
n
n
n
2
2.90
57.53
4.6
CRYSTALS WERE GROWN BY MIXING EQUAL VOLUMES OF A 25 MG/ML VANCOMYCIN SOLUTION AND 2.2 M NACL, 0.1 M SODIUM ACETATE, PH 4.6 (RESERVOIR BUFFER) AND THEN SUSPENDING THIS DROP OVER THE RESERVOIR. CRYSTALS WERE GROWN AT 293 K., VAPOR DIFFUSION - HANGING DROP
atom_site
chem_comp
entity
entity_poly
pdbx_branch_scheme
pdbx_chem_comp_identifier
pdbx_database_status
pdbx_entity_branch
pdbx_entity_branch_descriptor
pdbx_entity_branch_link
pdbx_entity_branch_list
pdbx_entity_nonpoly
pdbx_molecule
pdbx_nonpoly_scheme
pdbx_struct_assembly
pdbx_struct_assembly_gen
pdbx_struct_special_symmetry
pdbx_validate_close_contact
struct_asym
struct_conn
struct_site
struct_site_gen
atom_site
chem_comp
chem_comp_atom
chem_comp_bond
database_2
struct_conn
repository
Initial release
Carbohydrate remediation
repository
Remediation
Version format compliance
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Other
Other
Advisory
Atomic model
Data collection
Derived calculations
Other
Polymer sequence
Structure summary
Atomic model
Data collection
Database references
Derived calculations
Structure summary
1
0
1997-08-20
1
1
2011-06-14
1
2
2011-07-13
1
3
2011-07-27
1
4
2012-12-12
1
5
2016-10-19
2
0
2020-07-29
3
0
2023-11-15
_atom_site.B_iso_or_equiv
_atom_site.Cartn_x
_atom_site.Cartn_y
_atom_site.Cartn_z
_atom_site.auth_asym_id
_atom_site.auth_atom_id
_atom_site.auth_comp_id
_atom_site.auth_seq_id
_atom_site.label_alt_id
_atom_site.label_asym_id
_atom_site.label_atom_id
_atom_site.label_comp_id
_atom_site.label_entity_id
_atom_site.occupancy
_atom_site.type_symbol
_chem_comp.name
_chem_comp.type
_entity_poly.pdbx_seq_one_letter_code_can
_pdbx_database_status.process_site
_pdbx_struct_assembly.method_details
_pdbx_struct_assembly_gen.asym_id_list
_pdbx_struct_special_symmetry.label_asym_id
_pdbx_validate_close_contact.auth_asym_id_1
_pdbx_validate_close_contact.auth_asym_id_2
_pdbx_validate_close_contact.auth_seq_id_1
_pdbx_validate_close_contact.auth_seq_id_2
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.pdbx_ptnr1_label_alt_id
_struct_conn.pdbx_ptnr2_label_alt_id
_struct_conn.ptnr1_auth_asym_id
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_asym_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_atom_site.auth_atom_id
_atom_site.label_atom_id
_chem_comp.pdbx_synonyms
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.pdbx_leaving_atom_flag
A
BGC
8
n
C
BGC
1
A
RER
9
n
C
RER
2
B
BGC
8
n
D
BGC
1
B
RER
9
n
D
RER
2
DGlcpb
b-D-glucopyranose
b-D-Glcp
Glc
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH 2-ACETOXY-D-PROPANOIC ACID
CRYSTAL STRUCTURE OF VANCOMYCIN WITH D-LACTIC ACID
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH DI-ACETYL-LYS-D-ALA-D-ALA
SOLUTION STRUCTURE OF A82846B COMPLEXED WITH ITS CELL WALL PENTAPEPTIDE FRAGMENT
CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON
CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXD WITH TDP AND DESVANCOSAMINYL VANCOMYCIN
CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA COMPLEXED WITH TDP AND VANCOMYCIN
CRYSTAL STRUCTURE OF VANCOMYCIN COMPLEXED WITH N-ACETYL GLYCIN
CRYSTAL STRUCTURE OF TDP-VANCOSAMINYLTRANSFERASE GTFD COMPLEXED WITH TDP AND DESVANCOSAMINYL VANCOMYCIN.
CRYSTAL STRUCTURE OF VANCOMYCIN
Y
BNL
1997-01-23
REL
REL
oligosaccharide
WURCS=2.0/2,2,1/[a2122h-1b_1-5][ad621m-1a_1-5_3*C_3*N]/1-2/a2-b1
2
PDB2Glycan
1.1.0
WURCS
[][D-1-deoxy-Glcp]{[(2+1)][a-L-2-deoxy-Fucp3N]{}}
2
PDB-CARE
LINUCS
C1
O2
RER
BGC
2
1
2
O1
HO2
sing
n
n
ACY
ACETIC ACID
CL
CHLORIDE ION
HOH
water
31958
AMYCOLATOPSIS ORIENTALIS
sample
VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS
A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS
FURTHER GLYCOSYLATED BY A DISACCHARIDE MADE OF D-GLUCOSE
AND VANCOSAMINE.
HERE, VANCOMYCIN IS REPRESENTED BY GROUPING TOGETHER THE
SEQUENCE (SEQRES) AND THE TWO LIGANDS (HET) BGC AND RER.
Antibiotic
VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE,
GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8
AND 9) ON RESIDUE 4.
VANCOMYCIN
Glycopeptide
ACY
11
3
ACY
ACY
11
A
CL
21
4
CL
CL
21
A
CL
22
4
CL
CL
22
A
CL
21
4
CL
CL
21
B
CL
22
4
CL
CL
22
B
HOH
2001
5
HOH
HOH
2001
A
HOH
2002
5
HOH
HOH
2002
A
HOH
2003
5
HOH
HOH
2003
A
HOH
2004
5
HOH
HOH
2004
A
HOH
2005
5
HOH
HOH
2005
A
HOH
2006
5
HOH
HOH
2006
A
HOH
2007
5
HOH
HOH
2007
A
HOH
2008
5
HOH
HOH
2008
A
HOH
2009
5
HOH
HOH
2009
A
HOH
2010
5
HOH
HOH
2010
A
HOH
2011
5
HOH
HOH
2011
A
HOH
2012
5
HOH
HOH
2012
A
HOH
2013
5
HOH
HOH
2013
A
HOH
2014
5
HOH
HOH
2014
A
HOH
2015
5
HOH
HOH
2015
A
HOH
2016
5
HOH
HOH
2016
A
HOH
2017
5
HOH
HOH
2017
A
HOH
2018
5
HOH
HOH
2018
A
HOH
2019
5
HOH
HOH
2019
A
HOH
2020
5
HOH
HOH
2020
A
HOH
2021
5
HOH
HOH
2021
A
HOH
2022
5
HOH
HOH
2022
A
HOH
2023
5
HOH
HOH
2023
A
HOH
2024
5
HOH
HOH
2024
A
HOH
2025
5
HOH
HOH
2025
A
HOH
2026
5
HOH
HOH
2026
A
HOH
2027
5
HOH
HOH
2027
A
HOH
2028
5
HOH
HOH
2028
A
HOH
2029
5
HOH
HOH
2029
A
HOH
2030
5
HOH
HOH
2030
A
HOH
2031
5
HOH
HOH
2031
A
HOH
2032
5
HOH
HOH
2032
A
HOH
2033
5
HOH
HOH
2033
A
HOH
2034
5
HOH
HOH
2034
A
HOH
2001
5
HOH
HOH
2001
B
HOH
2002
5
HOH
HOH
2002
B
HOH
2003
5
HOH
HOH
2003
B
HOH
2004
5
HOH
HOH
2004
B
HOH
2005
5
HOH
HOH
2005
B
HOH
2006
5
HOH
HOH
2006
B
HOH
2007
5
HOH
HOH
2007
B
HOH
2008
5
HOH
HOH
2008
B
HOH
2009
5
HOH
HOH
2009
B
HOH
2010
5
HOH
HOH
2010
B
HOH
2011
5
HOH
HOH
2011
B
HOH
2012
5
HOH
HOH
2012
B
HOH
2013
5
HOH
HOH
2013
B
HOH
2014
5
HOH
HOH
2014
B
HOH
2015
5
HOH
HOH
2015
B
HOH
2016
5
HOH
HOH
2016
B
HOH
2017
5
HOH
HOH
2017
B
HOH
2018
5
HOH
HOH
2018
B
HOH
2019
5
HOH
HOH
2019
B
HOH
2020
5
HOH
HOH
2020
B
HOH
2021
5
HOH
HOH
2021
B
MLU
1
n
1
MLU
1
A
OMZ
2
n
2
OMZ
2
A
ASN
3
n
3
ASN
3
A
GHP
4
n
4
GHP
4
A
GHP
5
n
5
GHP
5
A
OMY
6
n
6
OMY
6
A
3FG
7
n
7
3FG
7
A
MLU
1
n
1
MLU
1
B
OMZ
2
n
2
OMZ
2
B
ASN
3
n
3
ASN
3
B
GHP
4
n
4
GHP
4
B
GHP
5
n
5
GHP
5
B
OMY
6
n
6
OMY
6
B
3FG
7
n
7
3FG
7
B
0.112
0.124
0.112
0.124
17479
software_defined_assembly
PISA
2
dimeric
1370
-32.8
2890
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
3_554
-y+1/2,x+1/2,z-1/4
crystal symmetry operation
14.2250000000
14.2250000000
-16.4600000000
1
A
HOH
2015
J
HOH
1
D
D
O2
O5
BGC
RER
1
2
2.01
B
1
D
D
C2
C1
BGC
RER
1
2
2.18
B
1
A
ASN
3
-100.65
-69.08
REFINEMENT WAS CARRIED OUT VS. F**2; SIMILAR 1,2 AND 1,3 DISTANCE RESTRAINTS WERE APPLIED TO THE TWO VANCOMYCIN MOLECULES. ALSO, RESTRAINTS WERE IMPOSED TO LIMIT DEVIATIONS OF RINGS AND PEPTIDE BONDS FROM PLANARITY AND DIFFERENCES IN ALONG-BOND COMPONENTS OF ADPS. ADPS FOR SOLVENT WERE RESTRAINED TO BE APPROXIMATELY ISOTROPIC, AND ANTIBUMPING RESTRAINTS WERE USED TO PREVENT SOLVENT WATER MOLECULES FROM VIOLATING MINIMUM CONTACT DISTANCES. CONJUGATE GRADIENT LEAST SQUARES WAS USED FOR MOST OF THE REFINEMENT, WITH BLOCKED LEAST SQUARES AT THE END.
0.124
0.124
0.89
4.00
2553
17899
3647
80.0
1
0.000
DIRECT METHODS
3
158.00
255.40
0.89
4.00
55
265
50
0
160
0.019
0.008
0.011
0.025
0.890
10.000
1AA5
17899
2.000
0.07600
1
100.0000
12.800
85.8
0.89
0.95
31.500
0.14300
1
5.60
69.3
model building
SHELXL-93
refinement
SHELXL-93
data reduction
MADNES
data reduction
PROCOR
data scaling
XSCALE
phasing
SHELXL-93
VANCOMYCIN
1
N
N
1
N
N
2
N
N
2
N
N
3
N
N
4
N
N
4
N
N
4
N
N
4
N
N
5
N
N
5
N
N
covale
1.352
both
A
MLU
1
A
C
MLU
1
1_555
A
OMZ
2
A
N
OMZ
2
1_555
covale
1.329
both
A
OMZ
2
A
C
OMZ
2
1_555
A
ASN
3
A
N
ASN
3
1_555
covale
1.389
none
A
OMZ
2
A
OH
OMZ
2
1_555
A
GHP
4
A
C5
GHP
4
1_555
covale
1.319
both
A
ASN
3
A
C
ASN
3
1_555
A
GHP
4
A
N
GHP
4
1_555
covale
1.355
both
A
GHP
4
A
C
GHP
4
1_555
A
GHP
5
A
N
GHP
5
1_555
covale
1.394
none
A
GHP
4
A
C3
GHP
4
1_555
A
OMY
6
A
OCZ
OMY
6
1_555
covale
1.414
one
A
GHP
4
A
O4
GHP
4
1_555
C
BGC
1
C
C1
BGC
1_555
covale
1.333
both
A
GHP
5
A
C
GHP
5
1_555
A
OMY
6
A
N
OMY
6
1_555
covale
1.499
one
A
GHP
5
A
C3
GHP
5
1_555
A
3FG
7
A
CG1
3FG
7
1_555
covale
1.337
both
A
OMY
6
A
C
OMY
6
1_555
A
3FG
7
A
N
3FG
7
1_555
covale
1.327
both
B
MLU
1
B
C
MLU
1
1_555
B
OMZ
2
B
N
OMZ
2
1_555
covale
1.316
both
B
OMZ
2
B
C
OMZ
2
1_555
B
ASN
3
B
N
ASN
3
1_555
covale
1.395
none
B
OMZ
2
B
OH
OMZ
2
1_555
B
GHP
4
B
C5
GHP
4
1_555
covale
1.341
both
B
ASN
3
B
C
ASN
3
1_555
B
GHP
4
B
N
GHP
4
1_555
covale
1.341
both
B
GHP
4
B
C
GHP
4
1_555
B
GHP
5
B
N
GHP
5
1_555
covale
1.383
none
B
GHP
4
B
C3
GHP
4
1_555
B
OMY
6
B
OCZ
OMY
6
1_555
covale
1.446
one
B
B
B
GHP
4
B
O4
GHP
4
1_555
D
BGC
1
D
C1
BGC
1_555
covale
1.414
one
A
A
B
GHP
4
B
O4
GHP
4
1_555
D
BGC
1
D
C1
BGC
1_555
covale
1.338
both
B
GHP
5
B
C
GHP
5
1_555
B
OMY
6
B
N
OMY
6
1_555
covale
1.505
one
B
GHP
5
B
C3
GHP
5
1_555
B
3FG
7
B
CG1
3FG
7
1_555
covale
1.321
both
B
OMY
6
B
C
OMY
6
1_555
B
3FG
7
B
N
3FG
7
1_555
covale
1.406
both
C
BGC
1
C
O2
BGC
1_555
C
RER
2
C
C1
RER
1_555
covale
1.099
both
B
D
BGC
1
D
O2
BGC
1_555
D
RER
2
D
C1
RER
1_555
covale
1.466
both
A
D
BGC
1
D
O2
BGC
1_555
D
RER
2
D
C1
RER
1_555
ANTIBIOTIC
GLYCOPEPTIDE, ANTIBIOTIC
A
GHP
5
A
GHP
5
1
A
OMY
6
A
OMY
6
6.04
B
GHP
5
B
GHP
5
1
B
OMY
6
B
OMY
6
18.86
NOR00681
NOR
1
NOR00681
1
7
1AA5
1
7
NOR00681
A
1
1
7
1
7
1AA5
1
7
NOR00681
B
1
1
7
96
P 43 21 2